Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals

39:23 | Feb 18th, 2016

Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.